Client Extranet
|
Site Map
|
RSS
About Us
Practices
People
Offices
News & Insights
Careers
Blogger
Delicious
Digg
Facebook
LinkedIn
Twitter
Email
Home
»
People
»
Andrew T Bayman
» Matters
Andrew T Bayman (Andy)
Partner, Tort Litigation & Environmental Practice Group Leader
ATLANTA
T: +1 404 572 3583
F: +1 404 572 5100
E-mail
CLOSE
[x]
All Offices
Abu Dhabi
Atlanta
Austin
Charlotte
Dubai
Frankfurt
Geneva
Houston
London
Moscow
New York
Paris
Riyadh
San Francisco
Silicon Valley
Singapore
Washington, D.C.
All Practices
Antitrust
Antitrust & IP
Antitrust Counseling
Antitrust Energy
Cartel Litigation
Civil Antitrust Litigation
EU Competition
Healthcare Antitrust
M&A / Joint Ventures
Pharma Antitrust Solutions
UK Competition and Regulatory
Appellate Litigation
Asian Practice
Asset Management
Bankruptcy/Restructuring
Climate Change
Commercial Disputes
Congressional Investigations
Construction and Procurement
Construction Litigation
Consumer Class Action
Copyright
Corporate Espionage & Competitive Intelligence
Corporate Finance
Corporate Governance
Corporate Plaintiffs Litigation
D&O Liability Litigation
Domestic Arbitration/ADR
E-Commerce
E-Discovery
Emerging Growth
Employee Benefits & Executive Compensation
Energy & Natural Resources
Arbitration
Construction and Procurement
Construction Dispute Resolution
Environmental Litigation
Finance
Financial Restructuring
Foreign Corrupt Practices Act
Intellectual Property
LNG
Maritime
Mergers and Acquisitions
Mining and Natural Resources
Nuclear
Oil & Gas
Oil & Gas Exploration and Production
Oil & Gas Litigation
Oil & Gas Midstream and Pipelines
Oil & Gas Oil Field Services
Oil & Gas Refining
Petrochemical
Power
Power Litigation
Private Equity
Project Development
Regulatory
Renewable/Alternative Energy
Tax
Tort Litigation
Environmental
Environmental Litigation
ERISA & Employee Benefits Litigation
FDA & Life Sciences
Financial Markets
Distressed Assets
Financial Markets Policy
Subprime and Capital Markets
Financial Services
Financial Services Litigation
First Amendment/Defamation
Franchise & Distribution
Franchise & Distribution Litigation
German Practice
Government Advocacy & Public Policy
Political Law
Healthcare Industry
Academic Medical Centers
Antitrust
Children’s Health
Civil Litigation
Class Actions
Clinical Research Compliance
Financial Restructuring
Government Advocacy/Public Policy
Government Investigations/FCA
Health Information Privacy & Security
Healthcare M&A
Healthcare Reform Task Force
Information Technology/EHRs
International Healthcare
Labor & Employment
Managed Care, Health Plans and Insurers
Private Equity
Provider Representation
RAC & MIC Audits and Appeals
Regulatory and Compliance
Reimbursement
Tax
Tax Exempt Bond Financings
Healthcare Litigation
Homeland Security
Infrastructure Finance
Insurance Coverage and Recovery
Intellectual Property
International
International Arbitration
International Trade/WTO
Islamic Finance
Arbitration
Asset Finance
Energy
Healthcare
Middle East & North Africa
Petrochemicals and Refining
Power and Water
Private Equity
Private Equity/Investment Funds
Project Finance
Projects and Construction
Real Estate
Saudi Arabia Practice
Joint Ventures / Strategic Alliances
Labor & Employment
Latin America Practice
Licensing
Marketing & Advertising Litigation
Mass Tort
Mergers & Acquisitions
Our Approach to Litigation
Outsourcing
Patents
Pharma/Biotech/Med Devices
Antitrust
Business Litigation
Corporate
Emerging Companies
FDA & Life Sciences
Government Advocacy
Government Investigations
Intellectual Property
International Arbitration
Labor & Employment
Products Liability/Mass Tort
Privacy & Information Security
Private Equity/Investment Funds
Private Finance
Product Liability Litigation
Professional Liability Litigation
Project & Equipment Finance
Public Finance
Real Estate
Russia Practice
Securities Litigation/D&O Liability
Special Matters/Government Investigations
Sports, Media & Entertainment
Tax
Tax Litigation
Tax-Exempt
Technology Transactions
Telecommunications
Toxic Tort Litigation
Trade Secrets & Non-Compete Litigation
Trademarks/False Advertising
Advanced Search
Profile
|
Matters
|
Recognition
|
News & Insights
Mr. Bayman’s recent legal experience includes:
Representation of pharmaceutical, medical device and foreign automobile manufacturers in product liability lawsuits. His clients have included GlaxoSmithKline, Merck, Olympus, Eli Lilly, Toyota, Nissan, Porsche, Mercedes-Benz, Isuzu, Mazda, Subaru, Kia, Medtronic Sofamor Danek, Weyerhaeuser, Packaging Corporation of America, and Club Car, among others.
Member of a King & Spalding team that is serving as national coordinating counsel and trial counsel in product liability litigation involving GSK’s antidepressant, Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program, ranked number one in the American Tort Reform Association’s 2010 list of “Hellhole Jurisdictions.” King & Spalding has been successful in defeating certification of both state and national classes of Paxil® consumers on consumer fraud, medical monitoring and personal injury allegations. Those MDL victories,
In Re Paxil Prods.
Liab. Litg.
218 F.R.D. 242, 203 U.S. Dist. LEXIS 21195 and 212 F.R.D. 539, 2003 U.S. Dist. LEXIS 1936 have been referred to as part of the “big four” pharmaceutical cases on denial of class certification and medical monitoring and consumer fraud cases.
See
In Re Prempro Prods. Liab. Lit.
, 2005 W.L. 2094974 (E.D. Ark. Aug. 30, 2005) fn. 78.
Served as national coordinating counsel for a large consumer healthcare product manufacturer and has supervised a national document collection and company-wide interviews for that client.
Represented a major medical device manufacturer as national coordinating counsel and lead trial counsel in product liability litigation involving a recalled medical device. Mr. Bayman has represented the company in class actions and individual lawsuits alleging death or serious injury due to a defect in the device.
Lead trial counsel or second chair trial counsel in 14 automotive product liability cases and in a dealership termination trial in the federal and state courts in Georgia, Mississippi and Alabama.
Achieved defense verdict for Nissan as trial counsel in the first-ever case tried involving an alleged defect in a motorized seatbelt system (
Smith-Green v. Nissan
).
Served as national trial counsel for Quest Diagnostics Incorporated, the country’s largest private clinical laboratory company, in lawsuits arising out of the interpretation of laboratory specimens.
Lead trial counsel in cases in Missouri and Ohio in which it was alleged that a misread Pap smear led to a delay in the diagnosis of cervical cancer and caused wrongful death and the loss of fertility.
Has argued before the Tenth Circuit, Eleventh Circuit and in the appellate courts of Georgia. Obtained a successful result as lead appellate counsel on behalf of Mazda in the case of
James
v. Mazda Motor Corporation, et. al.
, 222 F.3d 1323 (11th Cir. 2000). The court held that a claim that a vehicle was defective because it failed to incorporate an automatic lap belt was preempted.
PRACTICE AREAS
Product Liability Litigation
Healthcare Litigation
Mass Tort
Pharma Products Liability
Pharma/Biotech/Med Devices
Healthcare Industry
Healthcare Civil Litigation
EDUCATION
J.D., Vanderbilt University
AB,
magna cum laude
, Miami University-Oxford
ADMISSIONS
10th Circuit Court of Appeals
11th Circuit Court of Appeals
3rd Circuit Court of Appeals
Colorado District Court
Georgia
Georgia Middle District Court
Georgia Northern District Court
Georgia Southern District Court
Illinois Central District Court
Michigan Western District Court
U.S. Supreme Court
Wisconsin Eastern District Court